MAPT and Alzheimer disease: Although recent work has highlighted enhanced microglial activation in mixed DLB + AD patients (van Wetering et al., 2024), how combined tau, Aβ and α-syn pathologies may synergistically influence the full neuroinflammatory response remains unclear.